Advocacy

In collaboration with the House Cancer Caucus, the Society for Immunotherapy of Cancer (SITC) co-hosted a congressional briefing, “The Promise of Cancer Immunotherapy,” on Wednesday, Oct. 30, 2019, in the Rayburn House Office Building. Leading experts discussed various aspects of cancer immunotherapy and the promise that lies ahead with further support from the federal government. Rep. Brian Higgins (D-NY), a co-chairman of the House Cancer Caucus, also delivered remarks.

Panelists included:

• George J. Weiner, MD – University of Iowa Holden Comprehensive Cancer Center
• Marc S. Ernstoff, MD – Roswell Park Comprehensive Cancer Center
• Michael B. Atkins, MD – Georgetown Lombardi Comprehensive Cancer Center
• Crystal L. Mackall, MD – Stanford University
• Kathryn Bell  –  Cancer Patient Survivor

As always, SITC encourages stakeholders in the field to reach out to members of Congress in support of funding and advancing cancer immunotherapy research.

More details and photos can be found by viewing past tweets and by searching the hashtag, #SITContheHill.

Cancer Immunotherapy Fact Sheets

Transforming Cancer Treatment

Advances in cancer treatment have evolved dramatically during the past decade, and continue to change and shape the way oncologists treat patients and train staff. Understanding cancer treatment options can be confusing for patients and their families.

In collaboration with Friends of Cancer Research (Friends), the Society for Immunotherapy of Cancer (SITC) has developed new value fact sheets in a language accessible by both patients and advocates outlining the pathways and unique benefits of immunotherapy compared to other cancer treatments.

Please click on the infographics below to learn more about critical data and basic information regarding cancer immunotherapy.

This project is supported, in part, by a grant from Pfizer, Inc./EMD Serono.